drugset
drugset / Trial / NCT03116685

A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

NCT03116685 ↗

Phase 3 Completed 25 enrolled OxThera
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy and safety of OC5 in patients with PH.

Timeline

Start
2018-01-09
Primary completion
2021-04-15
Completion
2021-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxabact OC5 Unknown — —

Indications

primary hyperoxaluria